Effect of cellular senescence on the growth of HER2-positive breast cancers

Keyphrases

• Cellular Senescence 100%
• Senescent Cells 100%
• HER2-positive Breast Cancer 100%
• Patient-derived Xenograft 66%
• Interleukin-6 50%
• HER2-positive 50%
• Secretome 50%
• Confidence Interval 33%
• Human Epidermal Growth Factor Receptor 2 (HER2) 33%
• Oncogene-induced Senescence 33%
• Tumor 16%
• Tumor Cells 16%
• Tumor Suppressor 16%
• Biological Methods 16%
• Transgenic Mice 16%
• Human Breast Cancer 16%
• Overexpressing 16%
• Oncogene 16%
• Senescence 16%
• Statistical Test 16%
• Receptor Tyrosine Kinase 16%
• Proliferating Cells 16%
• HER2-positive Tumors 16%
• Senescence-associated Secretory Phenotype 16%
• Pro-tumorigenic 16%
• Tumor Volume 16%
• Tumor Model 16%
• Ectopic Overexpression 16%
• Advanced Breast Cancer 16%
• Suppression Mechanism 16%

Medicine and Dentistry

• Cellular Senescence 100%
• Xenograft 100%
• Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer 100%
• Neoplasm 75%
• Oncogene 75%
• Interleukin 6 75%
• Cytokine 50%
• Breast Cancer 50%
• Protein Tyrosine Kinase 25%
• Cell Proliferation 25%
• Tumor Model 25%
• Tumor Cell 25%
• Transgenic Mouse 25%
• Tumor Suppressor Protein 25%

Biochemistry, Genetics and Molecular Biology

• Oncogene 100%
• Secretome 100%
• Interleukin 6 100%
• Cytokine 66%
• Tumor Suppressor Protein 33%
• Statistical Test 33%
• Transgenic Mouse 33%
• Cell Proliferation 33%
• Receptor Tyrosine Kinase 33%
• Tumor Volume 33%